Covid-19 Antibody Therapy
- All
- News
- Videos
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron
German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing treatment options if the new variant prevails.
-
COVID-19 Antibody Discovered That Can Neutralise All Known SARS-CoV-2 Strains, Claim Researchers
Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
COVID-19 Antibody Therapy May Lower Hospitalisations, Finds Study
COVID-19 patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalisation or emergency medical care than those who did not receive the therapy, according to a new study.
-
Eli Lilly Says Its Antibody Therapy May Reduce Covid Hospitalisations
Eli Lilly and Co.'s experimental antibody treatment for Covid-19 reduced the rate at which symptomatic patients were hospitalized compared to a placebo, according to preliminary study results released by the company and its partner.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
"Only The Pain Of Needle Prick": COVID-19 Plasma Donors Share Experience
The process of donating plasma to treat COVID-19 is not very complex and can be done in just two hours, a donor in Delhi has told NDTV. One of the most discussed methods of treatment of the diseased caused by the novel coronavirus is plasma therapy, which involves the transfusion of plasma from a convalescent coronavirus patient to a critical patie...
-
Plasma Therapy For COVID-19: A Possible Treatment For Coronavirus?
Plasma therapy: The convalescent plasma therapy aims at using antibodies from the blood of a recovered COVID-19 patient, to treat those who are critically ill after being infected with the virus.
-
COVID-19: India In Final Stages Of Framing Protocols For Clinical Trial Of Plasma Therapy
India is in the final stages of framing a protocol for conducting clinical trial for convalescent plasma therapy, which uses antibodies from the blood of cured patients, to treat severely-ill COVID-19 patients, a senior ICMR official said.
-
On Covid Antibody Therapy, Top Virologist: "Unethical, Unscientific"
Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".
-
German Lab Tests Find Certain Antibody Therapies Lose out Against Omicron
German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant, likely reducing treatment options if the new variant prevails.
-
COVID-19 Antibody Discovered That Can Neutralise All Known SARS-CoV-2 Strains, Claim Researchers
Molecular Biology Consortium based at Berkeley Lab's Advanced Light Source (ALS) claims to have discovered an antibody that can neutralise all known SARS-CoV-2 strains, including the new mutants.
-
Monoclonal Antibody Therapy Improved Parameters In 2 Covid Patients: Delhi Hospital
Clinical parameters of two COVID-19 patients improved significantly within 12 hours of administering monoclonal antibody therapy, doctors at Sir Ganga Ram Hospital in Delhi said on Wednesday.
-
Regeneron Claims Its Covid-19 Antibody Therapy Demonstrated Promise in Hospitalised Patients
Casirivimab and imdevimab are not authorised for use in patients who are hospitalised or require oxygen therapy due to Covid-19, or for people currently using chronic oxygen therapy because of an underlying comorbidity
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
COVID-19 Antibody Therapy May Lower Hospitalisations, Finds Study
COVID-19 patients who were administered a novel antibody had fewer symptoms and were less likely to require hospitalisation or emergency medical care than those who did not receive the therapy, according to a new study.
-
Eli Lilly Says Its Antibody Therapy May Reduce Covid Hospitalisations
Eli Lilly and Co.'s experimental antibody treatment for Covid-19 reduced the rate at which symptomatic patients were hospitalized compared to a placebo, according to preliminary study results released by the company and its partner.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
"Only The Pain Of Needle Prick": COVID-19 Plasma Donors Share Experience
The process of donating plasma to treat COVID-19 is not very complex and can be done in just two hours, a donor in Delhi has told NDTV. One of the most discussed methods of treatment of the diseased caused by the novel coronavirus is plasma therapy, which involves the transfusion of plasma from a convalescent coronavirus patient to a critical patie...
-
Plasma Therapy For COVID-19: A Possible Treatment For Coronavirus?
Plasma therapy: The convalescent plasma therapy aims at using antibodies from the blood of a recovered COVID-19 patient, to treat those who are critically ill after being infected with the virus.
-
COVID-19: India In Final Stages Of Framing Protocols For Clinical Trial Of Plasma Therapy
India is in the final stages of framing a protocol for conducting clinical trial for convalescent plasma therapy, which uses antibodies from the blood of cured patients, to treat severely-ill COVID-19 patients, a senior ICMR official said.
